drugset / Trial / NCT05863975

Treatment of HPV Infection in Perimenopausal and Postmenopausal Women

NCT05863975

Phase 4 Unknown 150 enrolled Qianfoshan Hospital
RandomizedSequentialSingle-blindTreatment

Summary

A randomized controlled study was conducted to determine the effects of vaginal estrogen and human interferon alpha 2b vaginal effervescent capsules on vaginal microecology in perimenopausal and postmenopausal women. To determine whether there is a synergistic effect between the two in the treatment of HPV infection in perimenopausal and postmenopausal women. To observe the effects of two drugs alone and combined on the vaginal immune environment of patients.

Timeline

Start
2023-07-01
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Promestriene Other / unclassified 0.1 g Other
Subject Promestriene Other / unclassified 1 g Other
Subject human interferon alpha 2b Unknown Other